Companies: 10,795·Total market cap: $144.5T
Verano Holdings Corp.

Verano Holdings Corp.

VRNOFOTCHealthcare
$1.30
+$0.10(+8.33%)
Market Cap$470360643
P/E Ratio
52W High$1.85
52W Low$0.41
Overview

Verano Holdings Corp. (VRNOF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · VRNOF · as of Jun 10, 2026

Key Statistics

EPS (TTM)vrnof eps ttm · vrnof earnings per shareEarnings history
PE Ratio (TTM)vrnof pe ratio ttm · vrnof price to earningsPE Ratio deep dive
Revenue (TTM)vrnof revenue ttm · vrnof annual revenueFull revenue history
Dividend YieldNo Dividenddoes vrnof pay dividends · vrnof dividend yieldDividend history
Shares Outstandingvrnof shares outstanding · vrnof floatShares outstanding history
Next EarningsTBAvrnof earnings date · vrnof next earningsEarnings history

About Verano Holdings Corp.

CEOGeorge P. Archos
IPO DateFeb 18, 2021
Employees3,800
CountryUS
Websiteverano.com

Verano Holdings Corp. functions as a comprehensive, multi-state cannabis enterprise based in the United States. Its operations cover the entire cannabis supply chain, from cultivation and processing t…

what is verano holdings corp. · vrnof stock overview · verano holdings corp. company profile · who is verano holdings corp. ceo · vrnof OTC · verano holdings corp. headquarters · verano holdings corp. business segments

About Stock Overview & Key Data

Verano Holdings Corp. (VRNOF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 18, 2021. As of the latest trading session, VRNOF stock price is $1.30, with a market capitalization of $470.4M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Verano Holdings Corp. (VRNOF) stock price is $1.30. The stock is traded on OTC under the ticker symbol VRNOF. The 52-week range is $0.41 – $1.85.

VRNOF stock priceVRNOF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 10, 2026Not investment advice